Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

For knowledge about patent expiration dates and ongoing patent challenges

— Generic pharma, Canada

To get information on expired patents

— Patent Attorney, USA

To be aware of drugs likely to come off patent soon to help budget

— Hospital pharmacist, UK

To identify the patency situation for APIs worldwide

— Pharmaceutical professional, Egypt

To get information about data exclusivity, basic and constraining patents in the United States and Europe

— Business development manager, Turkey

Generated: May 24, 2017

DrugPatentWatch Database Preview

Simvastatin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for simvastatin and what is the scope of simvastatin patent protection?

Simvastatin is the generic ingredient in three branded drugs marketed by Lupin, Biocon Limited, Oxford Pharms, Zydus Pharms Usa, Dr Reddys Labs Inc, Ivax Sub Teva Pharms, Accord Hlthcare, Synthon Pharms, Sandoz Inc, Merck, Mylan Pharms Inc, Tcg Fluent Pharma, Micro Labs Ltd, Sun Pharm Inds Ltd, Watson Labs, Aurobindo Pharma, Hetero Labs Ltd Iii, and Merck Sharp Dohme, and is included in eighteen NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Simvastatin has eight patent family members in eleven countries.

There are thirty-nine drug master file entries for simvastatin. Sixty-four suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: simvastatin

Tradenames:3
Patents:10
Applicants:18
NDAs:18
Drug Master File Entries: see list39
Suppliers / Packagers: see list64
Bulk Api Vendors: see list75
Clinical Trials: see list146
Patent Applications: see list6,960
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:simvastatin at DailyMed

Pharmacology for Ingredient: simvastatin

Drug ClassHMG-CoA Reductase Inhibitor
Mechanism of ActionHydroxymethylglutaryl-CoA Reductase Inhibitors

Tentative approvals for SIMVASTATIN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe5MGTABLET; ORAL
► Subscribe► Subscribe80MGTABLET; ORAL
► Subscribe► Subscribe40MGTABLET; ORAL
ADD ALERT
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme
JUVISYNC
simvastatin; sitagliptin phosphate
TABLET;ORAL202343-001Oct 7, 2011DISCNYesNo7,078,381► Subscribe ► Subscribe
Merck
ZOCOR
simvastatin
TABLET;ORAL019766-004Dec 23, 1991ABRXYesNo► Subscribe► Subscribe
Dr Reddys Labs Inc
SIMVASTATIN
simvastatin
TABLET;ORAL077752-005Jan 23, 2008ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Inc
SIMVASTATIN
simvastatin
TABLET;ORAL077752-002Dec 20, 2006ABRXNoNo► Subscribe► Subscribe
Merck Sharp Dohme
JUVISYNC
simvastatin; sitagliptin phosphate
TABLET;ORAL202343-001Oct 7, 2011DISCNYesNo7,326,708► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To obtain a list of all currently off-patent approved small molecule therapeutics or those that will come off patent in the next 5 years

— Licensing / business development, Saudi Arabia

For access to patents for competitive analysis and project managment

— Pharmaceutical industry consultant, USA

To find drug patent expirations in the North Africa market

— Business development, India

To get patent expiry dates for molecules in South Africa

— Operations manager, India

To know about pharmaceutical patents and their expiration dates

— Pharmaceutical R&D, Venezuela

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot